Covered recipient · General Payments record
ALEXANDER R DAVIS
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2024–2025
$422.60
- Reported across 9 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $402.10 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Madrigal Pharmaceuticals | $169.89 | 2 |
| EVOKE PHARMA, INC. | $125.00 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.39 | 1 |
| Ipsen Biopharmaceuticals, Inc | $21.76 | 1 |
| ABBVIE INC. | $21.24 | 1 |
| Novo Nordisk AS | $21.12 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (8)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.24 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201732677 | CMS |
| EVOKE PHARMA, INC. | $125.00 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243916929 | CMS |
| Ipsen Biopharmaceuticals, Inc | $21.76 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208885157 | CMS |
| Madrigal Pharmaceuticals | $142.27 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248253941 | CMS |
| Madrigal Pharmaceuticals | $27.62 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248253945 | CMS |
| Novo Nordisk Inc | $21.12 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188999523 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.39 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231789201 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.70 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223854739 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.